Badrinath Konety

Badrinath Konety

University of Minnesota-Twin Cities

H-index: 76

North America-United States

About Badrinath Konety

Badrinath Konety, With an exceptional h-index of 76 and a recent h-index of 42 (since 2020), a distinguished researcher at University of Minnesota-Twin Cities,

His recent articles reflect a diverse array of research interests and contributions to the field:

Application of artificial intelligence (AI) features of nuclear morphology from BLASST-1 (Bladder Cancer Signal Seeking Trial) of nivolumab, gemcitabine, and cisplatin in …

Dissemination of circulating tumor cells in breast and prostate cancer: Implications for early detection

Military service and health-related quality of life among gay and bisexual prostate cancer survivors: Results from the Restore-2 study

Re: Rakesh Heer, Rebecca Lewis, Thenmalar Vadiveloo, et al. A Randomized Trial of PHOTOdynamic Surgery in Non–muscle-invasive Bladder Cancer. NEJM Evid 2022; 1: EVIDoa2200092

Racial Differences in the Detection Rate of Bladder Cancer Using Blue Light Cystoscopy: Insights from a Multicenter Registry

Diagnostic yield of upper tract imaging performed for hematuria screening: Results from a national, privately-insured cohort

Mechanism of action of nadofaragene firadenovec-vncg

MP31-17 VARIATION IN GENOMIC TESTING AMONGST LOCALIZED PROSTATE CANCER PATIENTS UNDERGOING RADICAL PROSTATECTOMY OR RADIATION THERAPY: RESULTS FROM A POPULATION-BASED COHORT

Badrinath Konety Information

University

Position

Professor Urology

Citations(all)

20981

Citations(since 2020)

9342

Cited By

15737

hIndex(all)

76

hIndex(since 2020)

42

i10Index(all)

264

i10Index(since 2020)

181

Email

University Profile Page

University of Minnesota-Twin Cities

Google Scholar

View Google Scholar Profile

Top articles of Badrinath Konety

Title

Journal

Author(s)

Publication Date

Application of artificial intelligence (AI) features of nuclear morphology from BLASST-1 (Bladder Cancer Signal Seeking Trial) of nivolumab, gemcitabine, and cisplatin in …

Kamal Hammouda

Shilpa Gupta

Tilak Pathak

Guru P Sonpavde

Ewan Gibb

...

2024/2/1

Dissemination of circulating tumor cells in breast and prostate cancer: Implications for early detection

Song Yi Bae

Kaylee Judith Kamalanathan

Catalina Galeano-Garces

Badrinath R Konety

Emmanuel S Antonarakis

...

2024/4

Military service and health-related quality of life among gay and bisexual prostate cancer survivors: Results from the Restore-2 study

BMJ Mil Health

Alex J Bates

D Mitteldorf

BRS Rosser

CW Wheldon

EJ Polter

...

2024/3/27

Re: Rakesh Heer, Rebecca Lewis, Thenmalar Vadiveloo, et al. A Randomized Trial of PHOTOdynamic Surgery in Non–muscle-invasive Bladder Cancer. NEJM Evid 2022; 1: EVIDoa2200092

European Urology

Jonathan Sussman

Badrinath Konety

Hamed Ahmadi

2024/2

Racial Differences in the Detection Rate of Bladder Cancer Using Blue Light Cystoscopy: Insights from a Multicenter Registry

Cancers

Seyedeh-Sanam Ladi-Seyedian

Alireza Ghoreifi

Badrinath Konety

Kamal Pohar

Jeffrey M Holzbeierlein

...

2024/3/24

Diagnostic yield of upper tract imaging performed for hematuria screening: Results from a national, privately-insured cohort

Urologic Oncology: Seminars and Original Investigations

Eric Ballon-Landa

Alex Hannemann

Boris Gershman

Rodrigo Rodrigues Pessoa

Brian Olson

...

2024/1/1

Mechanism of action of nadofaragene firadenovec-vncg

Vikram M Narayan

Joshua J Meeks

Jørn S Jakobsen

Neal D Shore

Grannum R Sant

...

2024/3/15

MP31-17 VARIATION IN GENOMIC TESTING AMONGST LOCALIZED PROSTATE CANCER PATIENTS UNDERGOING RADICAL PROSTATECTOMY OR RADIATION THERAPY: RESULTS FROM A POPULATION-BASED COHORT

The Journal of Urology

Brett Wiesen

Justin Achua

Adam Warren

Badrinath Konety

Tyler Robin

...

2024/5

PD48-01 EFFICACY OF NADOFARAGENE FIRADENOVEC-VNCG FOR PATIENTS WITH BACILLUS CALMETTE-GUÉRIN-UNRESPONSIVE NON-MUSCLE-INVASIVE BLADDER CANCER: FINAL RESULTS FROM A PHASE 3 TRIAL

The Journal of Urology

Stephen A Boorjian

Vikram M Narayan

Badrinath R Konety

Viraj A Master

Neal D Shore

...

2024/5

Efficacy of intravesical nadofaragene firadenovec-vncg for patients with Bacillus Calmette-Guérin-unresponsive non-muscle-invasive bladder cancer: 36-month follow-up from a …

Urologic Oncology: Seminars and Original Investigations

Stephen A Boorjian

Vikram M Narayan

Viraj A Master

Badrinath R Konety

Neal D Shore

...

2024/3/1

Urinary Analysis of FGFR3 and TERT Gene Mutations Enhances Performance of Cxbladder Tests and Improves Patient Risk Stratification

The Journal of urology

Yair Lotan

Jay D Raman

Badrinath Konety

Siamak Daneshmand

Florian Schroeck

...

2023/4

A multi-institutional study of 1,111 men with 4K score, multiparametric magnetic resonance imaging, and prostate biopsy

Urologic Oncology: Seminars and Original Investigations

Jamie Thomas

Shrikanth Atluri

Isaac Zucker

Isildinha Reis

Deukwoo Kwon

...

2023/10/1

The Effects of Prostate Cancer Treatment on Role-In-Sex in Gay and Bisexual Men: Mixed Methods Results from the Restore-1 and Restore-2 Studies

The Journal of Sex Research

Alexander K Tatum

BR Simon Rosser

Christopher W Wheldon

Maria Beatriz Torres

Alex J Bates

...

2022/10/7

Stigma and Health

Trevor A Hart

Ramraajh Sharvendiran

Vijaya Chikermane

Ammaar Kidwai

Daniel Grace

...

2021

Genomic analysis from BLASST-1 (Bladder Cancer Signal Seeking Trial) of nivolumab, gemcitabine, and cisplatin in patients with MIBC undergoing cystectomy.

Shilpa Gupta

Vladimir Makarov

Guru P Sonpavde

Ewan Gibb

Sumati Gupta

...

2023/2/20

AI-based pathologic biomarker for pathologic downstaging in patients with muscle-invasive bladder cancer undergoing cystectomy after neoadjuvant nivolumab, gemcitabine, and …

Viswesh Krishna

Guru P Sonpavde

Sumati Gupta

Benjamin L Maughan

Neeraj Agarwal

...

2023/6/1

Optimum threshold of the 4Kscore for biopsy in men with negative or indeterminate multiparametric magnetic resonance imaging

BJUI Compass

Ricardo de Almeida S Jr

Jamie Thomas

Matthew M Mason

Maria F Becerra

Ali Merhe

...

2023/9

Is a restaging TURBT necessary in high-risk NMIBC if the initial TURBT was performed with blue light?

Urologic Oncology: Seminars and Original Investigations

Muhannad Alsyouf

Seyedeh-Sanam Ladi-Seyedian

Badrinath Konety

Kamal Pohar

Jeffrey M Holzbeierlein

...

2023/2/1

MP63-05 OUTCOMES IN PATIENTS (PTS) WITH BACILLUS CALMETTE-GUERIN (BCG)-UNRESPONSIVE HIGH-RISK (HR) NON-MUSCLE-INVASIVE BLADDER CANCER (NMIBC) WHO UNDERWENT RADICAL CYSTECTOMY …

The Journal of Urology

Girish S Kulkarni

Ashish M Kamat

Edward M Uchio

Mathieu Roumiguié

Laurence EM Krieger

...

2023/4

Defining the association between prolonged operative time and 90-day complications in patients undergoing radical cystectomy

Asian Journal of Urology

Peter Hanna

Joseph Zabell

Badrinath Konety

Christopher Warlick

2023/7/29

See List of Professors in Badrinath Konety University(University of Minnesota-Twin Cities)